biotechnology company in 3010 Boundary Rd Burnaby British Columbia V5m 4a1 Canadar
About 62 results.
BC Blueberry Biotechnology Co. Ltd.
Richmond, British Columbia CanadaBC Blueberry Biotechnology Ltd. Co. (BCBB) is headquartered in the beautiful British Columbia on the west coast of Canada.
Welichem Biotech Inc
Burnaby, British Columbia CanadaWelichem BioTech Inc. is a Canadian Biotech Company focused on developing Autoimmune Inflammatory Disease and Cancer pharmaceutical drugs.
Coastal Genomics
Burnaby, British Columbia CanadaThe Ranger from Coastal Genomics is the only instrument to offer turnkey automation for agarose gel loading, size selection, and sample extraction.
Segra International Corp.
Richmond, CanadaSegra is a specialist Company focused on producing standardized Cannabis products and tissue culture plantlets using Quality Management Systems, genetic verification, and facility design.
Phyton Biotech LLC
Delta, British Columbia CanadaGlobal leaders in plant cell fermentation. Leveraging our award-winning PCF® technology, Phyton Biotech is now the world’s largest producer of Taxane APIs.
ReFleX Wireless Inc
Vancouver, British Columbia CanadaReFleX Wireless - IoT Solution provider for healthcare applications
Precision NanoSystems Inc.
Vancouver, British Columbia CanadaThe NanoAssemblr platform enables research of the genetic basis of disease and scaling of nanoparticle drug formulations.
Phoenix Molecular Designs
Vancouver, British Columbia CanadaPhoenix Molecular Designs is a Vancouver based biotechnology company dedicated to researching and developing an innovative targeted drug to treat Triple Negative Breast Cancer. This therapy w…
good natured Products Inc. (formerly Solegear)
better everyday products and packaging made from plants, not petroleum
ImStar Therapeutics Inc.
Vancouver, CanadaImStar Therapeutics is a biotech company developing important new treatments for Amyotrophic Lateral Sclerosis (ALS) and neurodegenerative diseases
Aurin Biotech Inc.
Vancouver, British Columbia CanadaDeveloping breakthrough complement-targeted therapeutics.